Catalyst Wire Dossier Catalyst Wire Dossier

AFFITOPE PCSK9 vaccine - Variant A

· Affiris AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFFITOPE PCSK9 vaccine - Variant A, covering 2017-10-20 to 2017-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects [Phase 1]

See pricing